NEVRO's HF10 therapy runs at 10 kHz and maintains stable outcomes for chronic trunk pain over more than 2 years of continuous monitoring. Japan's Ministry of Health granted approval in early 2024 ...

New Delhi, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The global neurostimulation devices market was valued at US$ 9.84 billion in 2024 and is expected to reach US$ 22.64 billion by 2033 from, growing at a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

There is little official guidance on using cannabis after surgery. Research on the effects of cannabis on surgery, anesthesia, and surgical recovery lags behind its use. For this reason ...

What is stenosis after gastric bypass surgery? After gastric bypass surgery for weight loss, the new connection between the stomach pouch and the small intestine may narrow. This is called an ...

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 results ...

The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy, an SCS therapy that provides electrical pulses to the spinal cord to alleviate pain. The electrical pulses ...

About the Senza System and HF10 Therapy The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy, an SCS therapy that provides electrical pulses to the spinal cord to ...

The Princess of Wales is now in remission from cancer, with Kate sharing her "relief" after an emotional visit ... that at the time of her abdominal surgery in January, her condition was believed ...

REDWOOD CITY, Calif., Jan. 21, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic ...